Plant-Derived Vesicle-like Nanoparticles for Cancer Therapy: From Drug Delivery to Combined Immunotherapy
Antioxidants · 28.02.2026 · 15 (3) · 311
DOI: 10.3390/antiox15030311 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 28.02.2026. Verfasst von Jinying Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China. Die Arbeit nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Henan Province Science and Technology Research and Development Program Joint Fund, Special Project of Traditional Chinese Medicine Research in Henan Province.
Abstract (Originalsprache)
Plant-derived vesicle-like nanoparticles (PDVLNs) are a unique class of natural nanomaterials secreted by plant cells. Endowed with intrinsic biocompatibility, minimal immunogenicity, and a molecular cargo rich in lipids, proteins, nucleic acids, and unique metabolites, PDVLNs exhibit significant potential in cancer treatment. With the development of diverse engineering strategies and loading methods, PDVLNs have been well established as an ideal drug delivery platform for transporting a broad spectrum of anti-cancer agents, including nucleic acids, proteins, and conventional chemotherapeutics. Notably, accumulating evidence highlights PDVLNs as a novel nanoplatform for combined cancer immunotherapy. This review systematically summarizes the biogenesis, isolation methods, compositions, and anti-tumor activity and mechanisms of PDVLNs, emphasizing their synergistic applications with cancer immunotherapies. Finally, it also discusses the challenges related to production optimization, delivery efficiency, safety issues, and clinical translation facing current research. In the future, as mechanistic insights deepen and nanotechnology advances, PDVLNs are poised to become next-generation immunomodulatory nanoplatforms for enhanced cancer immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
- Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Zhengzhou 450046, China.
- The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou 450046, China.
ORCID-Profile: Mingsan Miao
Förderung
- the National Natural Science Foundation of China
- Henan Province Science and Technology Research and Development Program Joint Fund
- Special Project of Traditional Chinese Medicine Research in Henan Province
- Henan Provincial Science and Technology R&D Program Joint Fund (Cultivation Category of Advantageous Disciplines) Project
- Key Scientific Research Project of Higher Education Institutions in Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Zuo, Y., Sun, B., Wang, X., Tian, S., & Miao, M. (2026). Plant-Derived Vesicle-like Nanoparticles for Cancer Therapy: From Drug Delivery to Combined Immunotherapy. Antioxidants, 15(3), 311. https://doi.org/10.3390/antiox15030311
Vancouver
Zhang J, Zuo Y, Sun B, Wang X, Tian S, Miao M. Plant-Derived Vesicle-like Nanoparticles for Cancer Therapy: From Drug Delivery to Combined Immunotherapy. Antioxidants. 2026;15(3):311. doi:10.3390/antiox15030311
BibTeX
@article{Zhang2026,
author = {Zhang, Jinying and Zuo, Yuan and Sun, Bo and Wang, Xinxin and Tian, Shuo and Miao, Mingsan},
title = {Plant-Derived Vesicle-like Nanoparticles for Cancer Therapy: From Drug Delivery to Combined Immunotherapy},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {3},
pages = {311},
doi = {10.3390/antiox15030311}
}
EUVIMED